Breakthrough supportive care: Overcoming cancer anorexia/cachexia
A new drug is proven to offer significantly better outcomes for patients with non-small cell lung cancer who experience this debilitating side effect.
Diagnosis & Disease Information
Anamorelin improves appetite and body mass in patients with cancer anorexia-cachexia
A new drug, anamorelin, has been found to improve appetite and body mass in patients with advanced lung cancer who are experiencing cancer anorexia and cachexia.
Antibody halts cachexia from cancer
New research raises the prospect of more effective treatments for cachexia, a profound wasting of fat and muscle occurring in about half of all cancer patients.
Tumor factors block muscle repair to cause muscle wasting
A new study reveals that tumors release factors into the bloodstream that inhibit the repair of damaged muscle fibers, and that this contributes to muscle loss during cancer wasting.
- Loading...
Loading...
Loading... 
Loading...